SIP 1.55% $1.31 sigma pharmaceuticals limited

Personally ,when i read this from their half yearly,I thought it...

  1. 438 Posts.
    Personally ,when i read this from their half yearly,I thought it was a bit over the top,unless they were worried about backlash from possible reduced earnings ahead and that they were raising money at the same time to fund an acquisition and reduce debt.

    " Sigma maintains its previous guidance of modest growth in NPAT for the full year ending 31 January 2010, assuming:

    No changes to regulatory environment

    No major business disruptions

    No major changes in consumer or customer demand

    New product launches as scheduled and as budgeted

    No unusual competitor activities or initiatives or introduction of significant competitors

    Stable industrial climate

    No non-recurring items are anticipated in FY2010 H2 "

    IMHO ,this is their get out of jail free card, and if it is negative earning guidance tomorrow, they will use the above to support their position.
 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.